Updates are available Correction dated 2025-01-27
Click to view Correction: https://doi.org/10.1038/s41551-025-01356-1
-
Authors
Chen, Joshua C. https://orcid.org/0000-0003-4317-7108
Dhuliyawalla, Abdeali
Garcia, Robert https://orcid.org/0000-0001-8907-9867
Robledo, Ariadna https://orcid.org/0000-0002-7981-6103
Woods, Joshua E. https://orcid.org/0000-0001-5069-4678
Alrashdan, Fatima https://orcid.org/0000-0001-7605-1056
O’Leary, Sean https://orcid.org/0000-0003-3650-705X
Husain, Adam https://orcid.org/0009-0000-6040-7628
Price, Anthony https://orcid.org/0000-0002-8927-3384
Crosby, Scott
Felicella, Michelle M. https://orcid.org/0000-0003-0872-5113
Wakhloo, Ajay K. https://orcid.org/0000-0003-4355-2107
Karas, Patrick
Provenza, Nicole https://orcid.org/0000-0002-6952-5417
Goodman, Wayne
Sheth, Sameer A.
Sheth, Sunil A. https://orcid.org/0000-0003-0602-8509
Robinson, Jacob T. https://orcid.org/0000-0002-3509-3054
Kan, Peter https://orcid.org/0000-0001-6649-4128
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (U18EB029353)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
- License Information
-
More Information
Article History
Received: 16 October 2023
Accepted: 14 October 2024
First Online: 11 November 2024
Change Date: 27 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41551-025-01356-1
Competing interests
: J.T.R., Sunil A. Sheth, Sameer A. Sheth and J.E.W. receive monetary or equity compensation from Motif Neurotech. Sameer A. Sheth has consulting agreements with Boston Scientific, Zimmer Biomet, Koh Young, Neuropace, Sensoria Therapeutics and Varian Medical. Sunil A. Sheth has consulting agreements with Viz.ai, Penumbra, Medtronic and Imperative Care, as well as grant funding from the McNair Foundation and the NIH. The terms of these agreements have been reviewed and approved by Rice University, UTHealth and Baylor College of Medicine in accordance with their policies on conflicts of interest in research. A.K.W. is a cofounder of Deinde and P.K. is an investor in Deinde. The other authors declare no competing interests.
